T 0273/22 (Chimeric antibodies/REGENERON) of 31.08.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T027322.20230831
- Date of decision
- 31 August 2023
- Case number
- T 0273/22
- Online on
- 8 November 2023
- Petition for review of
- -
- Application number
- 14172437.7
- IPC class
- A01K 67/027
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- A method of producing an antibody comprising a human variable region and a rodent constant region
- Applicant name
- REGENERON PHARMACEUTICALS, INC.
- Opponent name
- Kymab Limited (opposition withdrawn)
Ligand Pharmaceuticals Incorporated
James Poole Limited
Novo Nordisk A/S (opposition withdrawn)
Merus N.V., Kymab Limited (opposition withdrawn)
Icely, Dominic - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 76(1)
- Keywords
- Divisional application - subject-matter extends beyond content of earlier application (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.